Finance

Beta
Lists
ALPEKA:BMV
Alpek SAB de CV
MXN 12,53
0,00%
(0,00) 1D
26 Jun., 14:00:00 GMT-6  ·   MXN
All symbols
SymbolPriceChange% Change
Generating top insights for ALPEKA...
Open
MXN 12,43
High
MXN 12,57
Low
MXN 12,40
Mkt. cap
26,40 mjd
Avg. vol.
6,20 m
Volume
2,61 m
52-wk high
MXN 13,00
52-wk low
MXN 8,07
EPS
-MXN 1,92
Shares outstanding
2,11 mjd
No. of employees
5 k
Open
MXN 12,43
High
MXN 12,57
Low
MXN 12,40
Mkt. cap
26,40 mjd
Avg. vol.
6,20 m
Volume
2,61 m
52-wk high
MXN 13,00
52-wk low
MXN 8,07
EPS
-MXN 1,92
Shares outstanding
2,11 mjd
No. of employees
5 k
News stories
From sources across the web
Profile
Alpek S.A.B. de C.V., known as Alpek, is a Mexican chemical manufacturing company headquartered in San Pedro Garza García, in Nuevo León, Mexico. It is one of the largest PET and PTA producers in the Americas and the sole producer of polypropylene and caprolactam in Mexico. It is the largest business unit of the industrial conglomerate Alfa, representing 37% of its revenues for 2014. It is also the largest chemical company in Mexico according to Expansion magazine. Alpek reported revenues of $6.5 billion for 2014. It operates facilities in 21 sites in the United States, Mexico, Brazil, Argentina and Chile and employs 5,000 people. Alpek was listed on the Mexican Stock Exchange on April 26, 2012, and is a constituent of the IPC, the main benchmark index of the Mexican Stock Exchange. Wikipedia
About Alpek SAB de CV
CEOJose de Jesus Valdez Simancas
Employees5,21 k
Founded1975
Headquarters-
SectorCommodity chemical
Websitealpek.com
Previous reportsAll values in MXN
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in MXN
Jun. 2025
Sep. 2025
Des. 2025
Mrt. 2026
Revenue
32,79 mjd
31,07 mjd
27,96 mjd
29,76 mjd
Cost of goods sold
30,83 mjd
28,77 mjd
26,90 mjd
26,77 mjd
Cost of revenue
30,83 mjd
28,77 mjd
26,90 mjd
26,77 mjd
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,41 mjd
1,31 mjd
1,41 mjd
1,32 mjd
Operating expense
1,35 mjd
2,13 mjd
1,23 mjd
1,36 mjd
Total operating expenses
32,18 mjd
30,90 mjd
28,13 mjd
28,14 mjd
Operating income
606,54 m
175,50 m
-170,79 m
1,62 mjd
Other non operating income
-188,89 m
-306,02 m
-174,02 m
-282,59 m
EBT including unusual items
504,34 m
-528,82 m
-781,51 m
-730,83 m
EBT excluding unusual items
504,34 m
-528,82 m
-888,66 m
951,22 m
Income tax expense
1,03 mjd
143,99 m
646,34 m
184,90 m
Effective tax rate
203,40%
-27,23%
-82,70%
-25,30%
Other operating expenses
-61,44 m
813,89 m
-183,82 m
46,33 m
Net income
-571,99 m
-807,34 m
-1,56 mjd
-1,12 mjd
Net profit margin
-1,74%
-2,60%
-5,60%
-3,76%
Earnings per share
-0,27
-0,19
-0,70
-
Interest and investment income
67,71 m
67,06 m
56,36 m
32,55 m
Interest expense
-555,43 m
-595,00 m
-583,54 m
-519,48 m
Net interest expenses
-487,72 m
-527,94 m
-527,18 m
-486,93 m
Depreciation and amortization charges
-
-
-
-
EBITDA
1,91 mjd
1,45 mjd
788,71 m
2,86 mjd
Gain or loss from assets sale
7,13 m
4,97 m
-91,77 m
-1,62 m
AI content may include mistakes. Learn more

Research

What's on your mind?
Give me an overview of ALPEKA
Explore what’s possible
Create portfolio
Deep Search
AI content may include mistakes. Learn more